Open Orphan - New contract win
ORPH Mon, 10 Aug 2020, 08:40am BST
Open Orphan was founded in 2017, with the goal of becoming Europe’s leading rare disease and orphan drug focused pharma services company by a management team with extensive industry and financial expertise.
Industry: Health Care
Contact: +353 (01) 6440007
Dublin 2, Ireland
Cathal Friel, Executive Chairman of Open Orphan plc, a rapidly growing specialist CRO pharmaceutical services company which is the world leader in the testing of vaccines and antivirals using human challenge clinical trials, provides an update on the signing of a new contract with a top 3 Pharma Company.